{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:41:46Z","timestamp":1791333706494,"version":"4.3.1"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"InFLAMES Flagship Programme of the Academy of Finland","award":["337530"],"award-info":[{"award-number":["337530"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic active lesions are promotors of neurodegeneration and disease progression in multiple sclerosis. They harbour a dense rim of activated innate immune cells at the lesion edge, which promotes lesion growth and thereby induces damage. Conventional MRI is of limited help in identifying the chronic active lesions, so alternative imaging modalities are needed. Objectives were to develop a PET-based automated analysis method for phenotyping of chronic lesions based on lesion-associated innate immune cell activation and to comprehensively evaluate the prevalence of these lesions in the various clinical subtypes of multiple sclerosis, and their association with disability. In this work, we use 18 kDa translocator protein-PET imaging for phenotyping chronic multiple sclerosis lesions at a large scale. For this, we identified 1510 white matter T1-hypointense lesions from 91 multiple sclerosis patients (67 relapsing\u2013remitting patients and 24 secondary progressive patients). Innate immune cell activation at the lesion rim was measured using PET imaging and the 18 kDa translocator protein-binding radioligand 11C-PK11195. A T1-hypointense lesion was classified as rim-active if the distribution volume ratio of 11C-PK11195-binding was low in the plaque core and considerably higher at the plaque edge. If no significant ligand binding was observed, the lesion was classified as inactive. Plaques that had considerable ligand binding both in the core and at the rim were classified as overall-active. Conventional MRI and disability assessment using the Expanded Disability Status Scale were performed at the time of PET imaging. In the secondary progressive cohort, an average of 19% (median, interquartile range: 11\u201326) of T1 lesions were rim-active in each individual patient, compared to 10% (interquartile range: 0\u201320) among relapsing\u2013remitting patients (P = 0.009). Secondary progressive patients had a median of 3 (range: 0\u201311) rim-active lesions, versus 1 (range: 0\u201318) among relapsing\u2013remitting patients (P = 0.029). Among those patients who had rim-active lesions (n = 63), the average number of active voxels at the rim was higher among secondary progressive compared to relapsing\u2013remitting patients (median 158 versus 74; P = 0.022). The number of active voxels at the rim correlated significantly with the Expanded Disability Status Scale (R = 0.43, P &amp;lt; 0.001), and the volume of the rim-active lesions similarly correlated with the Expanded Disability Status Scale (R = 0.45, P &amp;lt; 0.001). Our study is the first to report in vivo phenotyping of chronic lesions at large scale, based on 18 kDa translocator protein-PET. Patients with higher disability displayed a higher proportion of rim-active lesions. The in vivo lesion phenotyping methodology offers a new tool for individual assessment of smouldering (rim-active) lesion burden.<\/jats:p>","DOI":"10.1093\/braincomms\/fcab301","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T15:30:13Z","timestamp":1640014213000},"source":"Crossref","is-referenced-by-count":50,"title":["Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-5684","authenticated-orcid":false,"given":"Marjo","family":"Nylund","sequence":"first","affiliation":[{"name":"Turku PET Centre, Turku, Finland"},{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Sucksdorff","sequence":"additional","affiliation":[{"name":"Turku PET Centre, Turku, Finland"},{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Matilainen","sequence":"additional","affiliation":[{"name":"Turku PET Centre, Turku, Finland"},{"name":"Faculty of Science and Engineering, \u00c5bo Akademi University, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7796-0064","authenticated-orcid":false,"given":"Eero","family":"Polvinen","sequence":"additional","affiliation":[{"name":"Turku PET Centre, Turku, Finland"},{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouni","family":"Tuisku","sequence":"additional","affiliation":[{"name":"Turku PET Centre, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Airas","sequence":"additional","affiliation":[{"name":"Turku PET Centre, Turku, Finland"},{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"issue":"3","key":"2022021509232736400_fcab301-B1","first-page":"527","article-title":"Progressive multiple sclerosis: From pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"issue":"11","key":"2022021509232736400_fcab301-B2","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/glia.22597","article-title":"Mechanisms of white matter damage in multiple sclerosis","volume":"62","author":"Lassmann","year":"2014","journal-title":"Glia"},{"issue":"Pt 11","key":"2022021509232736400_fcab301-B3","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"issue":"5","key":"2022021509232736400_fcab301-B4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann Neurol"},{"issue":"5","key":"2022021509232736400_fcab301-B5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"2022021509232736400_fcab301-B6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fimmu.2018.00255","article-title":"Significance and in vivo detection of iron-laden microglia in white matter multiple sclerosis lesions","volume":"9","author":"Gillen","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"2022021509232736400_fcab301-B7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/mrm.25358","article-title":"Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker","volume":"73","author":"Wang","year":"2015","journal-title":"Magn Reson Med"},{"issue":"1","key":"2022021509232736400_fcab301-B8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","article-title":"Slow expansion of multiple sclerosis iron rim lesions: Pathology and 7 T magnetic resonance imaging","volume":"133","author":"Dal-Bianco","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"7","key":"2022021509232736400_fcab301-B9","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI86198","article-title":"Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions","volume":"126","author":"Absinta","year":"2016","journal-title":"J Clin Invest"},{"key":"2022021509232736400_fcab301-B10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple sclerosis lesions with disability in vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"2022021509232736400_fcab301-B11","doi-asserted-by":"crossref","first-page":"e57573","DOI":"10.1371\/journal.pone.0057573","article-title":"Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions","volume":"8","author":"Mehta","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"2022021509232736400_fcab301-B12","first-page":"2055217320915480","article-title":"Evaluation of the \u2018ring sign\u2019 and the \u2018core sign\u2019 as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis","volume":"6","author":"Blindenbacher","year":"2020","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"1","key":"2022021509232736400_fcab301-B13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/awy296","article-title":"Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions","volume":"142","author":"Kaunzner","year":"2019","journal-title":"Brain"},{"issue":"Pt 11","key":"2022021509232736400_fcab301-B14","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","article-title":"The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity","volume":"123","author":"Banati","year":"2000","journal-title":"Brain"},{"issue":"6","key":"2022021509232736400_fcab301-B15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.0b013e3182635645","article-title":"Increased PK11195 PET binding in the cortex of patients with MS correlates with disability","volume":"79","author":"Politis","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"2022021509232736400_fcab301-B16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2967\/jnumed.113.131698","article-title":"In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand \u00b9\u00b9C-PK11195","volume":"55","author":"Rissanen","year":"2014","journal-title":"J Nucl Med"},{"issue":"9","key":"2022021509232736400_fcab301-B17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2967\/jnumed.116.187161","article-title":"C-PBR28 and 18F-PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis","volume":"58","author":"Datta","year":"2017","journal-title":"J Nucl Med"},{"issue":"1","key":"2022021509232736400_fcab301-B18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-017-0340-x","article-title":"TSPO imaging using the novel PET ligand [18F]GE-180: Quantification approaches in patients with multiple sclerosis","volume":"7","author":"Vomacka","year":"2017","journal-title":"EJNMMI Res"},{"issue":"3","key":"2022021509232736400_fcab301-B19","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1212\/NXI.0000000000000443","article-title":"Microglial activation, white matter tract damage, and disability in MS","volume":"5","author":"Rissanen","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"2022021509232736400_fcab301-B20","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1212\/NXI.0000000000000574","article-title":"Natalizumab treatment reduces microglial activation in the white matter of the MS brain","volume":"6","author":"Sucksdorff","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"2022021509232736400_fcab301-B21","first-page":"127","article-title":"Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients","volume":"102","author":"Debruyne","year":"2002","journal-title":"Acta Neurol Belg."},{"issue":"2","key":"2022021509232736400_fcab301-B22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"3","key":"2022021509232736400_fcab301-B23","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1212\/NXI.0000000000000691","article-title":"Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging","volume":"7","author":"Bezukladova","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"4","key":"2022021509232736400_fcab301-B24","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1016\/j.neuroimage.2011.11.032","article-title":"An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis","volume":"59","author":"Schmidt","year":"2012","journal-title":"Neuroimage."},{"issue":"1","key":"2022021509232736400_fcab301-B25","first-page":"158","article-title":"Reference and target region modeling of [11C]-(R)-PK11195 brain studies","volume":"48","author":"Turkheimer","year":"2007","journal-title":"J Nucl Med."},{"issue":"8","key":"2022021509232736400_fcab301-B26","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/jcbfm.2012.59","article-title":"Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies","volume":"32","author":"Yaqub","year":"2012","journal-title":"J Cereb Blood Flow Metab."},{"issue":"4","key":"2022021509232736400_fcab301-B27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/practneurol-2015-001139","article-title":"Association of British Neurologists: Revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis","volume":"15","author":"Scolding","year":"2015","journal-title":"Pract Neurol."},{"key":"2022021509232736400_fcab301-B28","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awaa275","article-title":"Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis","volume":"143","author":"Sucksdorff","year":"2020","journal-title":"Brain."},{"issue":"4","key":"2022021509232736400_fcab301-B29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat Rev Neurol."},{"issue":"5","key":"2022021509232736400_fcab301-B30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1471-4159.2009.06537.x","article-title":"Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders","volume":"112","author":"von Bernhardi","year":"2010","journal-title":"J Neurochem."},{"issue":"10","key":"2022021509232736400_fcab301-B31","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1177\/1352458514533230","article-title":"The role of microglial activation in disease progression","volume":"20","author":"Correale","year":"2014","journal-title":"Mult Scler."},{"issue":"11","key":"2022021509232736400_fcab301-B32","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/brain\/awz287","article-title":"A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis","volume":"142","author":"Nutma","year":"2019","journal-title":"Brain."},{"key":"2022021509232736400_fcab301-B33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00259-020-05166-2","article-title":"Cellular sources of TSPO expression in healthy and diseased brain","volume":"49(1)","author":"Nutma","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"2022021509232736400_fcab301-B34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40478-019-0779-2","article-title":"The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions","volume":"7","author":"Park","year":"2019","journal-title":"Acta Neuropathol Commun."},{"issue":"7","key":"2022021509232736400_fcab301-B35","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain."},{"issue":"1","key":"2022021509232736400_fcab301-B36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12974-019-1612-3","article-title":"Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats","volume":"16","author":"Elo","year":"2019","journal-title":"J Neuroinflamm."},{"issue":"2","key":"2022021509232736400_fcab301-B37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00259-019-04550-x","article-title":"The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: A first-in man study","volume":"47","author":"Hagens","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"Pt 12","key":"2022021509232736400_fcab301-B38","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1093\/brain\/awr278","article-title":"Tracking iron in multiple sclerosis: A combined imaging and histopathological study at 7 Tesla","volume":"134","author":"Bagnato","year":"2011","journal-title":"Brain."},{"issue":"6","key":"2022021509232736400_fcab301-B39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ana.21582","article-title":"Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron","volume":"64","author":"Hammond","year":"2008","journal-title":"Ann Neurol."},{"issue":"1","key":"2022021509232736400_fcab301-B40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1148\/radiol.11110601","article-title":"Chronic multiple sclerosis lesions: Characterization with high-field-strength MR imaging","volume":"262","author":"Yao","year":"2012","journal-title":"Radiology."},{"issue":"5","key":"2022021509232736400_fcab301-B41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jon.12193","article-title":"Heterogeneity of multiple sclerosis white matter lesions detected with T2*-weighted imaging at 7.0 tesla","volume":"25","author":"Yao","year":"2015","journal-title":"J Neuroimaging."},{"issue":"7","key":"2022021509232736400_fcab301-B42","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3174\/ajnr.A4729","article-title":"Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7 T MRI","volume":"37","author":"Chawla","year":"2016","journal-title":"AJNR Am J Neuroradiol."},{"issue":"3","key":"2022021509232736400_fcab301-B43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jmri.21676","article-title":"Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging","volume":"29","author":"Haacke","year":"2009","journal-title":"J Magn Reson Imaging."},{"issue":"7","key":"2022021509232736400_fcab301-B44","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3174\/ajnr.A5660","article-title":"Identification of chronic active multiple sclerosis lesions on 3 T MRI","volume":"39","author":"Absinta","year":"2018","journal-title":"AJNR Am J Neuroradiol."},{"key":"2022021509232736400_fcab301-B45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/brain\/awaa436","article-title":"Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI","volume":"144","author":"Dal-Bianco","year":"2021","journal-title":"Brain."},{"key":"2022021509232736400_fcab301-B46","doi-asserted-by":"crossref","first-page":"102317","DOI":"10.1016\/j.msard.2020.102317","article-title":"Sex-specific differences in rim appearance of multiple sclerosis lesions on quantitative susceptibility mapping","volume":"45","author":"Tolaymat","year":"2020","journal-title":"Mult Scler Relat Disord."},{"issue":"4","key":"2022021509232736400_fcab301-B47","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3988\/jcn.2020.16.4.562","article-title":"Paramagnetic rims in multiple sclerosis and neuromyelitis optica spectrum disorder: A quantitative susceptibility mapping study with 3-T MRI","volume":"16","author":"Jang","year":"2020","journal-title":"J Clin Neurol."},{"issue":"2","key":"2022021509232736400_fcab301-B48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3174\/ajnr.A5482","article-title":"Combining quantitative susceptibility mapping with automatic zero reference (QSM0) and myelin water fraction imaging to quantify iron-related myelin damage in chronic active MS lesions","volume":"39","author":"Yao","year":"2018","journal-title":"AJNR Am J Neuroradiol."},{"issue":"4","key":"2022021509232736400_fcab301-B49","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: A retrospective autopsy cohort analysis","volume":"135","author":"Luchetti","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"5","key":"2022021509232736400_fcab301-B50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","article-title":"Immunopathology of secondary-progressive multiple sclerosis","volume":"50","author":"Prineas","year":"2001","journal-title":"Ann Neurol."},{"issue":"8","key":"2022021509232736400_fcab301-B51","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3174\/ajnr.A4726","article-title":"Lesion heterogeneity on high-field susceptibility MRI is associated with multiple sclerosis severity","volume":"37","author":"Harrison","year":"2016","journal-title":"AJNR Am J Neuroradiol."},{"issue":"9","key":"2022021509232736400_fcab301-B52","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/brain\/awz212","article-title":"Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis","volume":"142","author":"Elliott","year":"2019","journal-title":"Brain."}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcab301\/41890549\/fcab301.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/4\/1\/fcab301\/42470211\/fcab301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/4\/1\/fcab301\/42470211\/fcab301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T04:24:23Z","timestamp":1644899063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcab301\/6479693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcab301","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,12,22]]},"article-number":"fcab301"}}